Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arya Mariam Roy

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cureus|August 23, 2021
Intravascular Large B-Cell Lymphoma: A Diagnostic DilemmaArya Mariam Roy, Yadav Pandey, Derek Middleton, et al.
Scientific Reports|November 26, 2025
DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancerKohei Chida, Rongrong Wu, Arya Mariam Roy, et al.
Frontiers in Immunology|July 29, 2024
Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gapMalak Alharbi, Arya Mariam Roy, Jayasree Krishnan, et al.
Cancers|March 25, 2022
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic ReviewRohit Gosain, Medhavi Gupta, Arya Mariam Roy, et al.
Cancers|September 9, 2023
Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database AnalysisArya Mariam Roy, Changchuan Jiang, Stuthi Perimbeti, et al.
The Permanente Journal|January 23, 2021
Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case ReportArya Mariam Roy, Manojna Konda, George K Sidarous, et al.
Histopathology|December 17, 2024
Breast biomarkers evolution between primary and distant metastasis: incidence and significanceMaha Khedr, Shipra Gandhi, Arya Mariam Roy, et al.
JAMA Network Open|November 22, 2023
Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast CancerArya Mariam Roy, Archit Patel, Kayla Catalfamo, et al.
Breast Cancer Research and Treatment|July 17, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancerTakumi Sato, Masanori Oshi, Jing Li Huang, et al.
Research Square|April 8, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancerTakumi Sato, Masanori Oshi, Jing Li Huang, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cureus|August 23, 2021
Intravascular Large B-Cell Lymphoma: A Diagnostic DilemmaArya Mariam Roy, Yadav Pandey, Derek Middleton, et al.
Scientific Reports|November 26, 2025
DEPTH2 score was associated with cell proliferation and immune cell infiltrations but not with systemic treatment response in breast cancerKohei Chida, Rongrong Wu, Arya Mariam Roy, et al.
Frontiers in Immunology|July 29, 2024
Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gapMalak Alharbi, Arya Mariam Roy, Jayasree Krishnan, et al.
Cancers|March 25, 2022
Health-Related Quality of Life (HRQoL) in Neuroendocrine Tumors: A Systematic ReviewRohit Gosain, Medhavi Gupta, Arya Mariam Roy, et al.
Cancers|September 9, 2023
Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database AnalysisArya Mariam Roy, Changchuan Jiang, Stuthi Perimbeti, et al.
The Permanente Journal|January 23, 2021
Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case ReportArya Mariam Roy, Manojna Konda, George K Sidarous, et al.
Histopathology|December 17, 2024
Breast biomarkers evolution between primary and distant metastasis: incidence and significanceMaha Khedr, Shipra Gandhi, Arya Mariam Roy, et al.
JAMA Network Open|November 22, 2023
Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast CancerArya Mariam Roy, Archit Patel, Kayla Catalfamo, et al.
Breast Cancer Research and Treatment|July 17, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancerTakumi Sato, Masanori Oshi, Jing Li Huang, et al.
Research Square|April 8, 2024
CD133 expression is associated with less DNA repair, better response to chemotherapy and survival in ER-positive/HER2-negative breast cancerTakumi Sato, Masanori Oshi, Jing Li Huang, et al.
Pageof 6